NE

NERIUM BIOTECHNOLOGY INC

  • CIK: 0001429040
  • EIN: 14-1987900
  • Business address: 11467 HUEBNER ROAD, SUITE 175, SAN ANTONIO, Texas, 78230

Information

  • Mailing address
    11467 HUEBNER ROAD, SUITE 175, SAN ANTONIO, TX, 78230
  • Phone
    210-822-7908
  • State location
    Texas
  • State of incorporation
    N/A
  • Fiscal year end
    December 31
  • SIC
    2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
  • Filings
    N/A

About NERIUM BIOTECHNOLOGY INC

NERIUM BIOTECHNOLOGY INC (CIK: 0001429040) is an American company incorporated in the state of Texas. Head office is located at 11467 HUEBNER ROAD, SUITE 175, SAN ANTONIO, Texas, 78230. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. NERIUM BIOTECHNOLOGY INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
Nester Joseph B 0001610482 Nov-12-2020 officer: Sec-Treasurer
KNOCKE DENNIS R 0001610490 Nov-12-2020 director, officer: President
LEININGER PETER A 0001610497 Nov-12-2020 director
Bourg Henry C. 0001738516 Nov-12-2020 officer: CFO
Ulloa Gustavo 0001832129 Nov-12-2020 director
Al-Bassam Sadik 0001832164 Nov-12-2020 10 percent owner
Amadori Dan 0001832166 Nov-12-2020 director
Burke Michael J 0001832454 Nov-12-2020 director
Mitchell Kerry 0001832457 Nov-12-2020 director

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NERIUM BIOTECHNOLOGY INC

Filings Format Description Filed/Effective File/Film Number
REVOKED Document Acc-no: 9999999997-23-002999 (34 Act) Size: 286 KB May-26-2023

000-54051

23963665
NT 10-K Document

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT

Acc-no: 0001062993-21-003184 (34 Act) Size: 10 KB		 Mar-31-2021

000-54051

21791443
8-K Document

Current report filing

Acc-no: 0001062993-21-002058 (34 Act) Size: 84 KB		 Mar-01-2021

000-54051

21695463
NT 10-Q Document

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Acc-no: 0001062993-20-006578 (34 Act) Size: 13 KB		 Dec-28-2020

000-54051

201415013
8-K Document

Current report filing

Acc-no: 0001062993-20-006362 (34 Act) Size: 12 KB		 Dec-15-2020

000-54051

201389767
3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000613 ( Act) Size: 6 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000611 ( Act) Size: 7 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000609 ( Act) Size: 4 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000607 ( Act) Size: 5 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000605 ( Act) Size: 6 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000603 ( Act) Size: 6 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000602 ( Act) Size: 3 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000599 ( Act) Size: 4 KB		 Nov-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001019056-20-000597 ( Act) Size: 5 KB		 Nov-30-2020

SEC STAFF ACTION Document Acc-no: 9999999997-20-005350 ( Act) Size: 14 KB Nov-12-2020

CORRESP Document

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Acc-no: 0001062993-20-005521 ( Act) Size: 3 KB		 Nov-12-2020

CORRESP Document

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Acc-no: 0001062993-20-005520 ( Act) Size: 3 KB		 Nov-12-2020

10-12G/A Document

Amendment to Initial general form for registration of a class of securities pursuant to section 12(g)

Acc-no: 0001062993-20-005519 (34 Act) Size: 1816 KB		 Nov-12-2020

000-54051

201303496
UPLOAD Document Acc-no: 0000000000-20-010784 ( Act) Size: 38 KB Nov-10-2020

CORRESP Document

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Acc-no: 0001062993-20-005476 ( Act) Size: 4 KB		 Nov-10-2020

Recent 20 filings. View all NERIUM BIOTECHNOLOGY INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • NERIUM BIOTECHNOLOGY INC overview
  • NERIUM BIOTECHNOLOGY INC job
  • NERIUM BIOTECHNOLOGY INC stock
  • NERIUM BIOTECHNOLOGY INC ownership
  • NERIUM BIOTECHNOLOGY INC CEO
  • NERIUM BIOTECHNOLOGY INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Cordyceps Sunshine Biotech Holdings Co., Ltd.
Update: Jan 21, 2023
PSLY.COM, Inc.
Update: Aug 29, 2022
Jushi Holdings Inc.
Update: Aug 29, 2022
ZACHARY VENTURES INC
Update: Aug 25, 2022
WEIKANG BIO-TECHNOLOGY GROUP CO., INC.
Update: Aug 25, 2022
VITAQUEST INTERNATIONAL INC
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2104 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3760 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1793 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4595 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3197 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1675 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3294 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2137 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3005 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by